These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9302563)

  • 1. Histopathology and clinical assessment correlate with the cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors.
    Roth JJ; Reiver DM; Granick MS; Rothman VL; Nicosia RF; Tuszynski GP
    Histol Histopathol; 1997 Oct; 12(4):1013-8. PubMed ID: 9302563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
    Wakiyama T; Shinohara T; Shirakusa T; John AS; Tuszynski GP
    Histol Histopathol; 2001 Apr; 16(2):345-51. PubMed ID: 11332689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in colonic anastomotic healing tissue.
    Roth JJ; Buckmire MA; Rolandelli RH; Granick MS; Tuszynski GP
    Histol Histopathol; 1998 Oct; 13(4):967-71. PubMed ID: 9810490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancer.
    Roth JJ; Albo D; Rothman VL; Longaker MT; Granick MS; Long CD; Solomon MP; Tuszynski GP
    Ann Plast Surg; 1998 May; 40(5):494-501. PubMed ID: 9600434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1998 Moyer Award. Characteristics of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in burn wounds.
    Roth JJ; Hughes WB; DeClement FA; Hensell DO; Granick MS; Tuszynski GP
    J Burn Care Rehabil; 1998; 19(6):487-93. PubMed ID: 9848038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin 1 and its specific cysteine-serine-valine-threonine-cysteine-clycine receptor in fetal wounds.
    Roth JJ; Sung JJ; Granick MS; Solomon MP; Longaker MT; Rothman VL; Nicosia RF; Tuszynski GP
    Ann Plast Surg; 1999 May; 42(5):553-63. PubMed ID: 10340867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted image analysis of tumor sections for a new thrombospondin receptor.
    Arnoletti JP; Albo D; Jhala N; Granick MS; Solomon MP; Atkinson B; Rothman VL; Tuszynski GP
    Am J Surg; 1994 Nov; 168(5):433-6. PubMed ID: 7526719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.
    Albo D; Shinohara T; Tuszynski GP
    J Surg Res; 2002 Nov; 108(1):51-60. PubMed ID: 12443715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer.
    Wu MP; Young MJ; Tzeng CC; Tzeng CR; Huang KF; Wu LW; Chou CY
    Carcinogenesis; 2008 Jun; 29(6):1115-23. PubMed ID: 18413367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain.
    Tuszynski GP; Rothman VL; Papale M; Hamilton BK; Eyal J
    J Cell Biol; 1993 Jan; 120(2):513-21. PubMed ID: 8421063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen.
    Wang TN; Qian XH; Granick MS; Solomon MP; Rothman VL; Tuszynski GP
    Am J Surg; 1995 Nov; 170(5):502-5. PubMed ID: 7485743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
    Souazé F; Dupouy S; Viardot-Foucault V; Bruyneel E; Attoub S; Gespach C; Gompel A; Forgez P
    Cancer Res; 2006 Jun; 66(12):6243-9. PubMed ID: 16778199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
    Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
    Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of stromal thrombospondin-1 in motility and proteolytic activity of oral squamous cell carcinoma cells.
    Hayashido Y; Nakashima M; Urabe K; Yoshioka H; Yoshioka Y; Hamana T; Kitano H; Koizumi K; Okamoto T
    Int J Mol Med; 2003 Oct; 12(4):447-52. PubMed ID: 12964017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.
    Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC
    Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.